Protein kinase inhibitors as sensitizing agents for chemotherapy Zhe-Sheng Chen and Dong-Hua Yang, editors

Format:

Book

Contributor:

Chen, Zhe-Sheng (Jason), editor.

Yang, Dong-Hua, editor.

Series:

Cancer sensitizing agents for chemotherapy v. 4

Cancer sensitizing agents for chemotherapy volume 4

Language:

English

Subjects (All):

Protein-tyrosine kinase--Inhibitors--Therapeutic use.

Protein-tyrosine kinase.

Cancer--Chemotherapy.

Cancer.

Protein kinases--Therapeutic use.

Protein kinases.

Protein Kinases--therapeutic use.

Medical Subjects:

Protein Kinases--therapeutic use.

Genre:

Internet Resources

Physical Description:

1 online resource

Place of Publication:

London, United Kingdom Academic Press, an imprint of Elsevier [2019]

System Details:

text file

Summary:

Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials

Notes:

Includes bibliographical references and index

Online resource; title from PDF title page (EBSCO, viewed November 27, 2018)

Other Format:

Print version:

ISBN:

9780128127384

0128127384

9780128164358

0128164352

OCLC:

1076269079

Access Restriction:

Restricted for use by site license